Ledger.Open graph →
SEC Form D · Amendment · filed November 7, 2011

NGM BIOPHARMACEUTICALS INC

Offering
$55.7M
Sold
$55.4M
Exemption
—
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

People & firms on this filing (16)

Arthur D. Levinson · South San Francisco, CADirectorGail Naughton · Encinitas, CADirectorMichael Hormaechea · Boise, IDDirectorJames J. Lynch · HARTFORD, CTExec · DirectorPeter Svennilson · Gulf Stream, FLDirectorHelen Kim · South San Francisco, CAExecMarc Leschly · Palo Alto, CADirectorSteven J. Kapiloff · HARTFORD, CTExec · DirectorMonika Wingate · Madison, WIDirectorJane Boutelle · Madison, WIExec · DirectorMichael Phippen · Mill Valley, CAExec · DirectorElliott Elbaz · Mill Valley, CADirectorRobert Pinnick · Bend, ORExecRajan Sobhani · Plano, TXDirectorRavi Mohan · Menlo Park, CADirectorFrank G. Mazzola · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗